ArnabRayMDFACG

PubMed

• 16 citations
  Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection.
  Arnab Ray, Courtney Jones
  Future Microbiology. 2016-03-17
• 139 citations
  The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
  Manasi Agrawal, Olga C. Aroniadis, Lawrence J. Brandt, Colleen R. Kelly, Sarah G. Freeman
  Journal of Clinical Gastroenterology. 2015-08-01
• 137 citations
  Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
  Robert Orenstein, Erik R. Dubberke, Robert Hardi, Arnab Ray, Kathleen M. Mullane
  Clinical Infectious Diseases. 2016-03-01

Journal Articles

• Overview of the Management of Clostridium difficile infections  
  Ray, A, Garcia Diaz, J Rivera Rivera, K, Infectious Disease Special Edition, Gastroenterology Special Edition, 2014
• Histoplasmosis presenting as a hypopharyngeal mass in an immune compromised host  
  Ray, A. Gahunia, M., Practical Gastroenterology, 10/2010
• HSV-1 Migration in Latently Infected and Naïve Rabbits Following Penetrating Keratoplasty  
  Zheng, Marquart, Loutsch, Shah, Sainz, Ray, O’ Callaghan, Kaufman, Hill, Invest. Ophthalmol. Vis. Sci, 10/1/1999

Abstracts/Posters

• Results of the Phase 2 Punch CD Safety Study of RBX2660 (microbiota suspension) for Recurrent Clostridium difficile Infection
  Dubberke, Orenstein, Mullane, Hardi, Ray, Sobcinski, ECCMID, Denmark, 4/1/2015
• RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: Lessons Learned from the PUNCH CD Study
  Ray, Hardi, Ramesh, Sobcinski, ACG 2014, Philadelphia, 10/1/2014
• RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH CD Phase 2 Safety Study
  Ramesh, Misra, Ray, Smith, Sobcinski, ACG, Philadelphia, 10/1/2014
• A Long- Term Follow-Up Study of the Efficacy and Safety of Fecal Microbiota Transplant(FMT) for Recurrent/Severe/Complicated C. difficile Infection (CDI) in the Elderly.
  Agrawal, Aroniadis, Brandt, Kelly, Freeman, Surawicz, Broussard, Stollman, Giovanelli, Smith, Yen, Trivedi, Hubble, Kao, Borody, Finlayson, Ray, Smith, DDW, Chicago, 2014
• Multifocal Granular Cell Tumor
  Ray, Karr, ACG Regional Conference, New Orleans, 2012
• Endoscopic Ultrasound-Guided fine needle aspiration of pancreatic cysts with and without antibiotic prophylaxis: A retrospective analysis of infectious complications.
  Ray, Zacharia, ACG, San Antonio, 2010
• Gastrointestinal bleeding from hemosuccus pancreaticus.
  Ray, ACG Regional Conference, New Orleans, 2010
• Cryoglobulinemic Membranoproliferative Glomerulonephritis in a Liver Transplant Patient
  Ray, Bodana, Davis, Joshi, ACG Regional Conerence, New Orleans, LA, 2009
• Crohn’s perianal fistulas and the incidence of fecal incontinence
  Ray, Herdman, Koyama, Herline, Wise, Muldoon, Schwartz, Advances in Inflammatory Bowel Diseases Conference, Miami, 2006
• Crohn’s perianal fistulas and the incidence of fecal incontinence
  Ray, Herdman, Koyama, Herline, Wise, Muldoon, Schwartz, ACG, Honolulu, 2005
• Join now to see all

Lectures

• Achalasia Management - Endoscopic Dilation/Botox is the Way to Go” “Pathologic Gastroesophageal Reflux Disease - Chronic Medical Therapy is OK” 
  Pharyngoesophageal Dysfunction and Gastroesophageal Reflux Symposium. CME Conference - 9/2014
• Celiac Disease 
  Hello Health Television Show - 12/2013
• Making Sense of Probiotics 
  Ochsner Resident and Fellow Conference - 4/2013
• Fecal Microbiota Transplantation in Clostridium difficile infection 
  Citywide Infectious Disease Conference - 11/2012
• Join now to see all